| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.7M | — |
| Cost of Revenue | $5.8M | — |
| Gross Profit | $1.9M | — |
| R&D Expense | $280K | — |
| SG&A Expense | $21K | -95.0% |
| Operating Income | $236K | +158.4% |
| Interest Expense | $77K | +1223.7% |
| Income Tax | -$118K | — |
| Net Income | $203K | +149.7% |
| EPS (Basic) | $0.00 | +100.0% |
| EPS (Diluted) | $0.00 | +100.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $234K | — |
| Accounts Receivable | $3.1M | — |
| Inventory | $1.9M | — |
| Current Assets | $8.7M | — |
| Total Assets | $18.9M | — |
| Current Liabilities | $6.4M | +1336.3% |
| Total Liabilities | $7.1M | +1503.7% |
| Stockholders' Equity | $11.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Investing Cash Flow | $135K | — |
| Financing Cash Flow | $946K | +1631.8% |
| +2775.8% |